Pulse is an intelligent platform for clinical study protocol management, data review, and anomaly detectionβdesigned to dramatically accelerate study closure while ensuring regulatory compliance.
The traditional approach to clinical study management is plagued by inefficiencies
Average clinical study closure takes 6-12 months due to data discrepancies, query resolution, and manual review processes.
Up to 20% of clinical data contains anomalies that go undetected until late stages, causing expensive rework.
Clinical data managers spend 70% of their time on repetitive data review tasks instead of critical analysis.
Every day of delay costs pharmaceutical companies $600K-$8M depending on the drug's potential market.
Pulse combines advanced machine learning with deep clinical domain expertise
AI-powered engine that continuously monitors clinical data for inconsistencies, outliers, and protocol deviations in real-time.
Centralized platform for creating, versioning, and managing clinical study protocols with AI-assisted optimization.
Automated data review workflows that prioritize critical items and reduce manual effort by up to 80%.
Streamlined close-out processes with automated checklists, status tracking, and regulatory-ready documentation.
Built-in regulatory compliance features for FDA 21 CFR Part 11, ICH-GCP, GDPR, and HIPAA requirements.
Connect with your existing EDC, CTMS, eTMF, and other clinical systems through robust APIs and pre-built connectors.
Our proprietary anomaly detection engine uses advanced machine learning algorithms trained on millions of clinical data points to identify issues that human reviewers often miss.
Detect values outside expected ranges using adaptive thresholds that learn from study-specific patterns.
Identify impossible timelines, backdated entries, and suspicious timing patterns across visits.
Spot logical inconsistencies between related data points (e.g., pregnancy in male patients).
Detect unusual patterns at specific sites that may indicate data quality issues or fraud.
Pulse is designed from the ground up to meet the strictest regulatory requirements, ensuring validity, correctness, and complete compliance throughout your clinical studies.
Electronic Records and Electronic Signatures
Full compliance with FDA regulations governing electronic records, ensuring your clinical data has the same legal standing as paper records.
International Conference on Harmonisation
Adherence to internationally recognized ethical and scientific quality standards for clinical trials.
Industry Guidelines & Best Practices
Alignment with FDA's guidance documents for computerized systems in clinical investigations.
HIPAA, GDPR & Global Standards
Comprehensive data protection meeting international privacy requirements.
Pulse undergoes rigorous validation per GAMP 5 Category 4 guidelines, with complete IQ/OQ/PQ documentation, validated algorithms, and comprehensive change control procedures. Our validation package includes:
Quantifiable results that transform your clinical operations*
Reduce time from last patient out to database lock and study closure
Through reduced manual effort, fewer queries, and faster timelines
Catch data issues early before they become costly problems
Free your team to focus on high-value analysis and decision-making
Accelerate drug development with real-time data quality monitoring and intelligent anomaly detection across all trial phases.
Identify site-level data quality variations and ensure consistency across geographically distributed research sites.
Manage complex data streams from remote monitoring devices, ePRO systems, and home healthcare visits.
Handle diverse real-world data sources with automated quality checks and anomaly detection.
Our team contributes to cutting-edge research in clinical AI and natural language processing
This research explores parameter-efficient methods for clinical documentation summarization. Using the AGBonnet dataset (30,000 clinical cases), we demonstrate that Low-Rank Adaptation (LoRA) applied to fine-tuned models achieves 98% of full fine-tuning performance while training only 0.44% of parameters (1.77M vs 406M). This enables resource-efficient deployment of clinical summarization in real-world healthcare environments.
Note: This research focuses on clinical summarization techniques and is related to, but distinct from, the Pulse platform's study management capabilities.
See how Pulse can reduce your study closure time by 60% or more
π Your information is secure and will never be shared